In vitro Activity of Phenothiazine Derivatives in Enterococcus faecalis and Enterococcus faecium
- 24 January 2005
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 96 (1) , 33-36
- https://doi.org/10.1111/j.1742-7843.2005.pto960105.x
Abstract
The antimicrobial activity of the phenothiazine derivatives thioridazine and prochlorperazine have been evaluated with 11 Enterococcus faecalis strains and 9 Enterococcus faecium strains, originating from human infections and animal faecal flora. We found that all E. faecalis and E. faecium strains, regardless of their susceptibility to commonly used antibiotics, were inhibited by thioridazine at a concentration of 16-32 microg/ml and by prochlorperazine at a concentration of 32-64 microg/ml. Combinations of the antibiotics vancomycin or ampicillin and thioridazine and prochlorperazine at subinhibitory concentrations, could render vancomycin- or ampicillin-resistant bacteria sensitive to each of the antibiotics. Verapamil and reserpine, inhibitors of P-glycoprotein-mediated multidrug resistance, did not reduce resistance. Our results outline modification of resistance in enterococci induced by phenothiazine derivatives unrelated to P-glycoprotein-mediated multidrug resistance.Keywords
This publication has 13 references indexed in Scilit:
- Safety aspects of enterococci from the medical point of viewInternational Journal of Food Microbiology, 2003
- EfrAB, an ABC Multidrug Efflux Pump in EnterococcusfaecalisAntimicrobial Agents and Chemotherapy, 2003
- Comparison of the incidence of virulence determinants and antibiotic resistance between Enterococcus faecium strains of dairy, animal and clinical originInternational Journal of Food Microbiology, 2003
- Epidemic and Nonepidemic Multidrug-ResistantEnterococcus faeciumEmerging Infectious Diseases, 2003
- Vancomycin-Resistant Enterococci*Chest, 2003
- Phenothiazines and Thioxanthenes Inhibit Multidrug Efflux Pump Activity in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2003
- Vancomycin-resistant enterococci: why are they here, and where do they come from?The Lancet Infectious Diseases, 2001
- The E-Test applied to susceptibility tests of gonococci, multiply-resistant enterococci, and enterobacteriaceae producing potent β-lactamasesDiagnostic Microbiology and Infectious Disease, 1992
- The antibacterial action and R-factor-inhibiting activity by chlorpromazineCellular and Molecular Life Sciences, 1975
- Synthesen auf dem Phenothiazin‐Gebiet. 2. Mitteilung. N‐substituierte Mercaptophenothiazin‐DerivateHelvetica Chimica Acta, 1958